PJA1 and plasma cell myeloma: The small molecule inhibitor RTA402 can bind PJA1 protein to inhibit its expression and, in turn, inhibit cell growth in various cancers, such as leukaemia, multiple myeloma, lymphoma, breast cancer, pancreatic cancer and colon cancer59–63.